Navigation Links
New discovery on role of vital protein that fights meningitis

A University of Leicester researcher has discovered how a protein in the blood linked to defence against meningitis - plays a more vital role than previously understood in the bodys immune defence system.

The published research has helped to advance medical understanding of how the body defends against disease and heals itself.

The study also reveals that the same protein, Properdin discovered only half a century ago- can also harm internal organs under certain circumstances.

Lack of the protein in the human body has previously been linked to susceptibility to meningitis.

But the new findings by Dr Cordula Stover, of the Department of Infection, Immunity and Inflammation at the University of Leicester assign hitherto unappreciated importance to this protein of the immune defence.

Her work, funded by the Medical Research Council (MRC), is published in the form of two papers in the Journal of Immunology. It is being published in print on May 15.

Dr Stover, a Lecturer in Immunology, said: I have a broad interest in immune mechanisms of health and disease, though recently, I have focused on a particular component of the first line immune defence, a protein called Properdin.

Properdin deficiency in families, though rare, predisposes people to develop meningococcal meningitis, usually with poor outcome of the infection.

I hypothesised that the importance of Properdin extends beyond this particular infectious disease, and that indeed it is an important player in health generally, and that its importance becomes apparent in conditions involving both acute and chronic states of inflammation.

I was most delighted to obtain funding from the MRC to investigate this.

Now two of Dr Stovers papers, published in the Journal of Immunology, demonstrate that Properdin plays a significant role in the survival of conditions relating to surgical perforation of the gut and activation of the immune system by wall components of bacteria.

In conditions relating to multi-organ dysfunction, a complication which can occur in response to severe sepsis, Properdin however aggravates organ damage.

Dr Stover added: So far, the system Properdin is a part of - the so-called complement system - is classified as a first line, innate, acutely effective immune activation mechanism.

My work shows that the activity of Properdin extends beyond the acute phase and, importantly, that Properdin is stepping onto the stage as an important player in different inflammatory conditions.

As the worldwide burden of chronic inflammatory disease increases, it is of practical relevance to understand the contribution of this immune protein.

The history of Properdin extends about 50 years with the first significant biochemical characterisations made in the USA, however, subsequently, the UK has contributed tremendously with the characterisation of the Properdin gene and structural modelling of the Properdin protein.


Contact: Dr. Cordula Stover
University of Leicester

Related biology news :

1. University of Arizona scientist shares in discovery of microbe filaments power
2. Stopping unwanted cell death: Implications for drug discovery
3. Journey to the center of the earth: Discovery sheds light on mantle formation
4. UC San Diego researchers eliminate drug discovery bottleneck
5. Work with power grids leads to cell biology discovery
6. Surprising discovery from first large-scale analysis of biodiversity and biogeography of viruses
7. International team announces discovery of massive Jurassic marine reptile
8. Gene discovery made easier with powerful new networking technique
9. Weird water: Discovery challenges long-held beliefs about waters special properties
10. UBC discovery unlocks tree genetics, gives new hope for pine beetle defense
11. Leading researchers and experts gather to discuss latest advancements in drug discovery
Post Your Comments:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
(Date:10/9/2017)... ... 2017 , ... The Giving Tree Wellness Center announces the ... of consumers who are incorporating medical marijuana into their wellness and health regimens. ... operators of two successful Valley dispensaries, The Giving Tree’s two founders, Lilach Mazor ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available ... bioinformatics software to perform Hi-C metagenome deconvolution using their own facilities, supplementing ...
(Date:10/6/2017)... ... 06, 2017 , ... On Tuesday, October 24th, ABC² (Accelerate ... first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will be Dr. ... open to the public, but registration is required. , WHAT: ABC² Brain ...
Breaking Biology Technology: